Back
Invesco S&P 500® Equal Wt Real Estt ETF Vs. Keros Therapeutics Industry Stock Comparison
Buy
66
RSPR
Invesco S&P 500® Equal Wt Real Estt ETF
Last Price:
37.93
Seasonality Move:
1.65%
Sell
35
KROS
Keros Therapeutics
Last Price:
55.82
Seasonality Move:
37.33%
Buy
66
Invesco S&P 500® Equal Wt Real Estt ETF (RSPR)
is a Buy
Is Invesco S&P 500® Equal Wt Real Estt ETF a Buy, Sell or Hold?
- The current Invesco S&P 500® Equal Wt Real Estt ETF [RSPR] share price is $38.11. The Score for RSPR is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.
- RSPR is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
35
Keros Therapeutics (KROS)
is a Sell
Is Keros Therapeutics a Buy, Sell or Hold?
- The current Keros Therapeutics [KROS] share price is $57.32. The Score for KROS is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
- KROS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
RSPR Stock Price Chart
What is Invesco S&P 500® Equal Wt Real Estt ETF's stock price today?
-
The Invesco S&P 500® Equal Wt Real Estt ETF share price today is $38.11
The current trend is moderately bullish and RSPR is experiencing slight selling pressure.
KROS Stock Price Chart
What is Keros Therapeutics's stock price today?
-
The Keros Therapeutics share price today is $57.32
The current trend is moderately bullish and KROS is experiencing slight buying pressure.
RSPR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.76 | Buy |
| Relative Strength Index (14 RSI): | 66.54 | Buy |
| Chaikin Money Flow: | -5129 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (36.12 - 38.04) | Buy |
| Bollinger Bands (100): | (31.93 - 36.19) | Buy |
KROS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.54 | Buy |
| Relative Strength Index (14 RSI): | 69.78 | Buy |
| Chaikin Money Flow: | 11894 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (45.63 - 54.93) | Buy |
| Bollinger Bands (100): | (44.93 - 54.13) | Buy |
RSPR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 38.21 | Sell |
| 20-day SMA: | 37.44 | Buy |
| 50-day SMA: | 35.92 | Buy |
| 200-day SMA: | 33.07 | Buy |
| 8-day EMA: | 38.1 | Buy |
| 20-day EMA: | 37.44 | Buy |
| 50-day EMA: | 36.08 | Buy |
| 200-day EMA: | 33.45 | Buy |
KROS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 55.81 | Buy |
| 20-day SMA: | 51.2 | Buy |
| 50-day SMA: | 49.36 | Buy |
| 200-day SMA: | 52.15 | Buy |
| 8-day EMA: | 55.34 | Buy |
| 20-day EMA: | 52.61 | Buy |
| 50-day EMA: | 50.31 | Buy |
| 200-day EMA: | 49.54 | Buy |
Invesco S&P 500® Equal Wt Real Estt ETF Earnings Growth & RSPR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Keros Therapeutics Earnings Growth & KROS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.08 per share, an increase next quarter of $0.02 per share, an increase this year of $0.31 per share, and a decrease next year of $0.43 per share.
Invesco S&P 500® Equal Wt Real Estt ETF Technical Analysis
| Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Keros Therapeutics Technical Analysis
| Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||